About 5 to 6 percent of all diabetes cases are type 1, making it far less common than type 2. Globally, an estimated 9.5 million people are living with type 1 diabetes as of 2025. In the United States, roughly 2.1 million people have been diagnosed with it, which works out to about 0.55 percent of the adult population.
Type 1 as a Share of All Diabetes
When people hear “diabetes,” they’re usually thinking of type 2, which accounts for about 91 percent of diagnosed cases. Type 1 makes up 5.8 percent, with the remaining fraction classified as other types (such as gestational diabetes or rarer genetic forms). That ratio holds fairly steady across large population studies, though it shifts depending on age group. Among children and teenagers with diabetes, type 1 is the dominant form.
Global Numbers
The International Diabetes Federation estimated 9.5 million people worldwide were living with type 1 diabetes in 2025, up 13 percent from 8.4 million in 2021. That growth reflects both genuinely rising incidence and better detection in countries that previously undercounted cases. An estimated 513,000 new cases were diagnosed in 2025 alone, with the annual incidence climbing by about 2.4 percent per year.
Against a global population of roughly 8 billion, 9.5 million translates to just over 0.1 percent of all people on Earth. That tiny-sounding number masks significant regional differences.
Where Type 1 Diabetes Is Most Common
Northern Europe has the highest rates by a wide margin. Finland leads the world, with 52.2 new childhood cases per 100,000 people each year. Sweden follows at 44.1. But the top-ten list isn’t exclusively European: Kuwait (41.7), Qatar (38.1), Algeria (34.8), and Saudi Arabia (31.4) all rank among the highest. Canada (37.9), Norway (33.6), the United Kingdom (28.1), and Ireland (27.5) round out the list.
At the other end of the spectrum, parts of East Asia have dramatically lower rates. China, for example, sees fewer than 1 new adult-onset case per 100,000 people annually. That more than 30-fold gap between the highest and lowest countries is one of the biggest unsolved puzzles in diabetes research, pointing to a complex mix of genetic susceptibility and environmental triggers.
U.S. Prevalence by the Numbers
In the United States, 2.1 million people have diagnosed type 1 diabetes. That includes about 1.8 million adults aged 20 and older and 314,000 children and teenagers. Among U.S. adults, the prevalence works out to 0.55 percent, or roughly 1 in every 180 people.
The broader diabetes picture in the U.S. shows notable variation by race and ethnicity, though most of this data reflects type 2 (which dominates overall numbers). Total diagnosed diabetes rates among adults range from 7.1 percent in white, non-Hispanic populations to 15.7 percent in American Indian or Alaska Native populations. Black non-Hispanic adults (12.2 percent) and Hispanic adults (11.8 percent) also have higher overall diabetes rates. These disparities are largely driven by type 2 diabetes, but they shape the landscape in which type 1 cases are identified and managed.
Most New Cases Occur in Adults
Type 1 diabetes was once called “juvenile diabetes” because it frequently appears in childhood. That name turned out to be misleading. More than half of all new type 1 diagnoses now occur in adults. In some countries the proportion is even higher: in China, adults made up 65.3 percent of newly diagnosed type 1 cases in large population studies.
This matters because adult-onset type 1 is often misdiagnosed as type 2, especially in people over 30 who don’t fit the stereotype of a thin child suddenly becoming insulin-dependent. A delayed or incorrect diagnosis can mean months or years on the wrong treatment before the underlying autoimmune process is recognized. If you’re an adult diagnosed with type 2 diabetes but struggling to control blood sugar despite following a standard treatment plan, type 1 is worth investigating.
Why the Numbers Keep Rising
Type 1 diabetes incidence has been climbing steadily for decades, at roughly 2 to 3 percent per year globally. Genetics alone can’t explain that pace, since human DNA doesn’t change that fast. Researchers suspect environmental factors are involved: viral infections, changes in gut bacteria, dietary shifts in early life, and reduced exposure to certain microbes have all been studied, though no single trigger has been confirmed.
Better surveillance also plays a role. Countries that previously lacked diabetes registries are now counting cases more systematically, which inflates apparent increases. Still, even in countries with long-standing tracking systems like Finland and Sweden, the upward trend is real and sustained. The 13 percent jump in global prevalence between 2021 and 2025 reflects both more people developing the condition and more people surviving longer with it, thanks to improved insulin delivery and blood sugar monitoring technology.